Notably, we detected higher phospho-ERK1/2 levels in several NPC cell lines with higher serglycin and CD44 expression, including highly metastatic S18 and 5-8 F cell lines (Figure 4b, bottom panel). This evidence concerns the gene CD44 and nasopharyngeal carcinoma.